Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$37.88 - $43.77 $172,013 - $198,759
4,541 Added 83.29%
9,993 $427,000
Q4 2023

Feb 09, 2024

SELL
$31.71 - $38.95 $1.24 Million - $1.53 Million
-39,206 Reduced 87.79%
5,452 $211,000
Q3 2023

Nov 13, 2023

BUY
$37.32 - $49.29 $1.12 Million - $1.48 Million
29,944 Added 203.51%
44,658 $1.69 Million
Q2 2023

Aug 03, 2023

BUY
$39.98 - $47.68 $236,201 - $281,693
5,908 Added 67.09%
14,714 $670,000
Q1 2023

May 12, 2023

SELL
$37.58 - $52.57 $207,930 - $290,869
-5,533 Reduced 38.59%
8,806 $357,000
Q4 2022

Feb 13, 2023

BUY
$49.7 - $57.71 $197,408 - $229,224
3,972 Added 38.31%
14,339 $731,000
Q3 2022

Nov 07, 2022

SELL
$53.86 - $66.8 $81,113 - $100,600
-1,506 Reduced 12.68%
10,367 $558,000
Q2 2022

Aug 12, 2022

BUY
$63.83 - $80.0 $193,021 - $241,920
3,024 Added 34.17%
11,873 $763,000
Q1 2022

May 11, 2022

BUY
$76.85 - $89.45 $324,537 - $377,747
4,223 Added 91.29%
8,849 $686,000
Q4 2020

Feb 12, 2021

SELL
$75.39 - $82.36 $168,572 - $184,156
-2,236 Reduced 32.59%
4,626 $371,000
Q3 2020

Nov 09, 2020

BUY
$78.33 - $90.73 $175,145 - $202,872
2,236 Added 48.34%
6,862 $552,000
Q2 2020

Aug 05, 2020

BUY
$78.66 - $94.14 $363,881 - $435,491
4,626 New
4,626 $398,000
Q1 2020

May 11, 2020

SELL
$71.57 - $93.3 $1.09 Million - $1.43 Million
-15,297 Closed
0 $0
Q4 2019

Mar 19, 2020

BUY
$76.7 - $88.45 $909,125 - $1.05 Million
11,853 Added 344.16%
15,297 $1.28 Million
Q3 2019

Mar 19, 2020

SELL
$81.4 - $89.78 $12,291 - $13,556
-151 Reduced 4.2%
3,444 $301,000
Q2 2019

Mar 19, 2020

BUY
$73.44 - $82.41 $264,016 - $296,263
3,595 New
3,595 $294,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Bi Asset Management Fondsmaeglerselskab A Portfolio

Follow Bi Asset Management Fondsmaeglerselskab A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.